Elsevier

Neurobiology of Aging

Volume 16, Issue 2, March–April 1995, Pages 187-198
Neurobiology of Aging

Article
Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology

https://doi.org/10.1016/0197-4580(94)00150-2Get rights and content

Abstract

Increasing evidence supports the involvement of amyloid β-peptide (Aβ) and an excitotoxic mechanism of neuronal injury in the pathogenesis of Alzheimer's disease. However, approaches aimed at preventing Aβ toxicity and neurofibrillary degeneration are undeveloped. We now report that anticonvulsants (carbamazepine, phenytoin, and valproic acid) can protect cultured rat hippocampal neurons againsts Aβ- and glutamate-induced injury. Each of the anticonvulsant attentuated the elevated of intracellular free calcium levels [(Ca2+)i] elicited by Aβ or glutamate suggesting that their neuroprotective mechanism of action involved stabilization of [Ca2+]i. These compounds were effective at clinically relevant concentrations (carbamazepine, 100 nM-10 μM; phenytoin, 100 nM-1 μM; valproic acid, 100 nM-100 μM). The anticonvulsants suppressed glutamate-induced alterations in tau and ubiquitin immunoreactivities. Compounds that stabilize [Ca2+]i may afford protection against the kinds of insults believed to underlie neuronal injury in Alzheimer's disease.

References (89)

  • G. Grynkiewicz et al.

    A new generation of calcium indicators with greatly improved fluorescence properties

    J. Biol. Chem.

    (1985)
  • K. Kitagawa et al.

    Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage: Immunohistochemical investigation of dendritic damage

    Neuroscience

    (1989)
  • J.-Y. Koh et al.

    β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

    Brain Res.

    (1990)
  • M.P. Mattson et al.

    Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture

    Brain Res.

    (1989)
  • M.P. Mattson

    Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons

    Neuron

    (1990)
  • M.P. Mattson

    Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons

    Brain Res.

    (1992)
  • M.P. Mattson

    Calcium as sculptor and destroyer of neural circuitry

    Exp. Gerontol.

    (1992)
  • M.P. Mattson et al.

    Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF

    Brain Res.

    (1993)
  • M. Mullan et al.

    Genetic and molecular advances in Alzheimer's disease

    Trends Neurosci.

    (1993)
  • C.J. Pike et al.

    In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity

    Brain Res.

    (1991)
  • S. Ponchaut et al.

    In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions

    Biochem. Pharmacol.

    (1992)
  • P.E. Potter et al.

    Dephenylhydantoin attenuates hypoxia-induced release of 3H-glutamate from rat hippocampal slices

    Brain Res.

    (1991)
  • K.S. Rayevsky et al.

    GABA-ergic drugs: effects on conditioning, memory, and learning

    Pharmacol. Res. Commun.

    (1983)
  • R.M. Sapolsky

    Glucocorticoids, hippocampal damage and the glutamatergic synapse

    Prog. Brain Res.

    (1990)
  • P.-E. Sautiere et al.

    Tau antigenic changes induced by glutamate in rat primary culture model: A biochemical approach

    Neurosci. Lett.

    (1992)
  • D.J. Selkoe

    The molecular pathology of Alzheimer's disease

    Neuron

    (1991)
  • R. Siman et al.

    Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo

    Neuron

    (1988)
  • W.C. Taft et al.

    Phenytoin protects against ischemia-produced neuronal cell death

    Brain Res.

    (1989)
  • M.L. Zeise et al.

    Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro

    Brain Res.

    (1991)
  • N. Arispe et al.

    Alzheimer's disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum

  • H. Bading et al.

    Stimulation of tyrosine phosphorylation by NMDA receptor activation

    Science

    (1991)
  • J. Biernat et al.

    The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serineproline motifs upstream of the microtubule binding region

    EMBO J.

    (1992)
  • L.I. Binder et al.

    Differential localization of MAP-2 and tau in mammalian neurons in situ

    Ann. NY Acad. Sci.

    (1986)
  • P.A. Boxer et al.

    Comparison of phenytoin with noncompetitive N-methyl-d-aspartate antagonists in a model of focal brain ischemia in rat

    Stroke

    (1990)
  • J. Busciglio et al.

    Beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins

    J. Neurochem.

    (1993)
  • X-D. Cai et al.

    Release of excess amyloid β protein from a mutant amyloid b protein precursor

    Science

    (1993)
  • M.C. Chartier-Harlin et al.

    Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein

    Nature

    (1991)
  • D.W. Choi

    Ionic dependence of glutamate neurotoxicity

    J. Neurosci.

    (1987)
  • M. Citron et al.

    Mutation of the β-amyloid precursor protein in familial Alzheimer's disease causes increased β-protein production

    Nature

    (1993)
  • A. Copani et al.

    β-amyloid increases neuronal susceptibility to injury by glucose deprivation

    NeuroReport

    (1991)
  • R.J. DeLorenzo

    Antiepileptic drugs

    (1989)
  • G. Drewes et al.

    Mitogen activated protein (MAP) kinase transforms tau protein into an Alzhemeir-like state

    EMBO J.

    (1992)
  • E.M. Elliott et al.

    Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo

    J. Neurochem.

    (1993)
  • R. Etcheberrigaray et al.

    Soluble β-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels

    Science

    (1994)
  • Cited by (0)

    View full text